We treated ESCC cells with the RNA synthesis inhibitor actinomycin D (5 μg/mL) and found that the half-lives of IFI27 mRNA were significantly shorter in PABPC1-depleted cells compared to in control cells. This evidence concerns the gene PABPC1 and esophageal squamous cell carcinoma.